Show simple item record

dc.contributor.authorJones, Sarah
dc.contributor.authorUusna, Julia
dc.contributor.authorLangel, Ülo
dc.contributor.authorHowl, John
dc.date.accessioned2018-02-22T15:00:19Z
dc.date.available2018-02-22T15:00:19Z
dc.date.issued2015-12-14
dc.identifier.citationIntracellular Target-Specific Accretion of Cell Penetrating Peptides and Bioportides: Ultrastructural and Biological Correlates
dc.identifier.issn1043-1802
dc.identifier.issn1520-4812
dc.identifier.doi10.1021/acs.bioconjchem.5b00529
dc.identifier.urihttp://hdl.handle.net/2436/621132
dc.description.abstractCell penetrating peptide (CPP) technologies provide a viable strategy to regulate the activities of intracellular proteins that may be intractable to other biological agents. In particular, the cationic helical domains of proteins have proven to be a reliable source of proteomimetic bioportides, CPPs that modulate the activities of intracellular proteins. In this study we have employed live cell imaging confocal microscopy to determine the precise intracellular distribution of a chemically diverse set of CPPs and bioportides. Our findings indicate that, following efficient cellular entry, peptides are usually accreted at intracellular sites rather than being freely maintained in an aqueous cytosolic environment. The binding of CPPs to proteins in a relatively stable manner provides a molecular explanation for our findings. By extension, it is probable that many bioportides influence biological processes through a dominant-negative influence upon discrete protein–protein interactions. As an example, we report that bioportides derived from the leucine-rich repeat kinase 2 discretely influence the biology and stability of this key therapeutic target in Parkinson’s disease. The intracellular site-specific accretion of CPPs and bioportides can also be readily modulated by the attachment of larger cargoes or, more conveniently, short homing motifs. We conclude that site-specific intracellular targeting could be further exploited to expand the scope of CPP technologies.
dc.language.isoen
dc.publisherAmerican Chemical Society
dc.relation.urlhttp://pubs.acs.org/doi/10.1021/acs.bioconjchem.5b00529
dc.titleIntracellular Target-Specific Accretion of Cell Penetrating Peptides and Bioportides: Ultrastructural and Biological Correlates
dc.typeJournal article
dc.identifier.journalBioconjugate Chemistry
dc.contributor.institutionResearch Institute in Healthcare Science, Faculty of Science and Engineering, University of Wolverhampton, Wulfruna Street, Wolverhampton, WV1 1LY, United Kingdom
dc.contributor.institutionInstitute of Technology, University of Tartu, Nooruse 1, 50411, Tartu, Estonia
dc.contributor.institutionInstitute of Technology, University of Tartu, Nooruse 1, 50411, Tartu, Estonia
dc.contributor.institutionResearch Institute in Healthcare Science, Faculty of Science and Engineering, University of Wolverhampton, Wulfruna Street, Wolverhampton, WV1 1LY, United Kingdom
dc.source.volume27
dc.source.issue1
dc.source.beginpage121
dc.source.endpage129
html.description.abstractCell penetrating peptide (CPP) technologies provide a viable strategy to regulate the activities of intracellular proteins that may be intractable to other biological agents. In particular, the cationic helical domains of proteins have proven to be a reliable source of proteomimetic bioportides, CPPs that modulate the activities of intracellular proteins. In this study we have employed live cell imaging confocal microscopy to determine the precise intracellular distribution of a chemically diverse set of CPPs and bioportides. Our findings indicate that, following efficient cellular entry, peptides are usually accreted at intracellular sites rather than being freely maintained in an aqueous cytosolic environment. The binding of CPPs to proteins in a relatively stable manner provides a molecular explanation for our findings. By extension, it is probable that many bioportides influence biological processes through a dominant-negative influence upon discrete protein–protein interactions. As an example, we report that bioportides derived from the leucine-rich repeat kinase 2 discretely influence the biology and stability of this key therapeutic target in Parkinson’s disease. The intracellular site-specific accretion of CPPs and bioportides can also be readily modulated by the attachment of larger cargoes or, more conveniently, short homing motifs. We conclude that site-specific intracellular targeting could be further exploited to expand the scope of CPP technologies.


This item appears in the following Collection(s)

Show simple item record